U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 74

1.
Three cases of seromucinous carcinoma of the ovary arising in endometriotic cysts
Yukiko Taga, Yoshitsugu Chigusa, Sachiko Minamiguchi, Aki Kido, Naoki Horikawa, Akihito Horie, Junzo Hamanishi, Eiji Kondoh, Masaki Mandai, Ken Yamaguchi
Int Cancer Conf J. 2021 Jan; 10(1): 46–53. Published online 2020 Sep 21. doi: 10.1007/s13691-020-00447-x
PMCID:
PMC7797404
AbstractArticlePDF–2.1M
2.
Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis
Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama, Hiroaki Soyama, Tomoyuki Yoshikawa, Hitoshi Tsuda, Kenichi Furuya
J Gynecol Oncol. 2018 Mar; 29(2): e20. Published online 2017 Dec 22. doi: 10.3802/jgo.2018.29.e20
PMCID:
PMC5823981
AbstractArticlePDF–13M
3.
PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis
Bo Seong Yun, Seyeon Won, Ju-Hyun Kim, Nara Lee, Miseon Kim, Mi Kyoung Kim, Mi-La Kim, Yong Wook Jung, Ji Young Kim, Seok Ju Seong, Eunah Shin
J Ovarian Res. 2022; 15: 41. Published online 2022 Apr 6. doi: 10.1186/s13048-022-00975-5
PMCID:
PMC8985320
AbstractArticlePDF–1.1M
4.
WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma
Mark Richter, Tajhal Dayaram, Aidan G. Gilmartin, Gopinath Ganji, Sandhya Kiran Pemmasani, Harjeet Van Der Key, Jason M. Shohet, Lawrence A. Donehower, Rakesh Kumar
PLoS One. 2015; 10(2): e0115635. Published online 2015 Feb 6. doi: 10.1371/journal.pone.0115635
PMCID:
PMC4319922
AbstractArticlePDF–4.7M
5.
Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications
Weiwei Shan, Imelda Mercado-Uribe, Jing Zhang, Daniel Rosen, Shiwu Zhang, Jianjun Wei, Jinsong Liu
Cell Cycle. 2012 Jun 1; 11(11): 2107–2113. doi: 10.4161/cc.20544
PMCID:
PMC3368862
AbstractArticlePDF–2.1M
6.
Mixed Lineage Kinase 3 is Required for Matrix Metalloproteinase Expression and Invasion in Ovarian Cancer Cells
Yu Zhan, Widian F. Abi Saab, Nidhi Modi, Amanda M. Stewart, Jinsong Liu, Deborah N. Chadee
Exp Cell Res. Author manuscript; available in PMC 2013 Aug 15.
Published in final edited form as: Exp Cell Res. 2012 Aug 15; 318(14): 1641–1648. Published online 2012 May 28. doi: 10.1016/j.yexcr.2012.05.002
PMCID:
PMC3389280
AbstractArticlePDF–1.3M
7.
Endocervical-type Mucinous Borderline Tumors are Related to Endometrioid Tumors Based on Mutation and Loss of Expression of ARID1A
Chen Hsuan Wu, Tsui-Lien Mao, Russell Vang, Ayse Ayhan, Tian-Li Wang, Robert J. Kurman, Ie-Ming Shih
Int J Gynecol Pathol. Author manuscript; available in PMC 2012 Nov 20.
Published in final edited form as: Int J Gynecol Pathol. 2012 Jul; 31(4): 297–303. doi: 10.1097/PGP.0b013e31823f8482
PMCID:
PMC3501990
AbstractArticlePDF–3.5M
8.
Low-grade serous carcinomas of the ovary contain very few point mutations
Siân Jones, Tian-Li Wang, Robert J Kurman, Kentaro Nakayama, Victor E Velculescu, Bert Vogelstein, Kenneth W Kinzler, Nickolas Papadopoulos, Ie-Ming Shih
J Pathol. Author manuscript; available in PMC 2012 Nov 21.
Published in final edited form as: J Pathol. 2012 Feb; 226(3): 413–420. Published online 2011 Dec 20. doi: 10.1002/path.3967
PMCID:
PMC3503448
AbstractArticlePDF–1.5M
9.
Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis
Matthew Schwede, Dimitrios Spentzos, Stefan Bentink, Oliver Hofmann, Benjamin Haibe-Kains, David Harrington, John Quackenbush, Aedín C. Culhane
PLoS One. 2013; 8(3): e57799. Published online 2013 Mar 11. doi: 10.1371/journal.pone.0057799
PMCID:
PMC3594231
AbstractArticlePDF–483K
10.
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
Ali Bashashati, Gavin Ha, Alicia Tone, Jiarui Ding, Leah M Prentice, Andrew Roth, Jamie Rosner, Karey Shumansky, Steve Kalloger, Janine Senz, Winnie Yang, Melissa McConechy, Nataliya Melnyk, Michael Anglesio, Margaret TY Luk, Kane Tse, Thomas Zeng, Richard Moore, Yongjun Zhao, Marco A Marra, Blake Gilks, Stephen Yip, David G Huntsman, Jessica N McAlpine, Sohrab P Shah
J Pathol. 2013 Sep; 231(1): 21–34. Published online 2013 Aug 6. doi: 10.1002/path.4230
PMCID:
PMC3864404
AbstractArticlePDF–2.0M
11.
Poor survival with wild-type TP53 ovarian cancer?
Kwong-Kwok Wong, Daisy I. Izaguirre, Suetyan Kwan, Erin R. King, Michael T. Deavers, Anil K. Sood, Samuel C. Mok, David M. Gershenson
Gynecol Oncol. Author manuscript; available in PMC 2014 Jun 16.
Published in final edited form as: Gynecol Oncol. 2013 Sep; 130(3): 565–569. Published online 2013 Jun 22. doi: 10.1016/j.ygyno.2013.06.016
PMCID:
PMC4059202
AbstractArticlePDF–306K
12.
Pathobiology of ovarian carcinomas
Mojgan Devouassoux-Shisheboran, Catherine Genestie
Chin J Cancer. 2015 Jan; 34(1): 50–55. doi: 10.5732/cjc.014.10273
PMCID:
PMC4302089
AbstractArticlePDF–1.5M
13.
Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases
Li Liang, Adriana Olar, Na Niu, Yi Jiang, Wenjun Cheng, Xiu-Wu Bian, Wentao Yang, Jing Zhang, Anna Yemelyanova, Anais Malpica, Zhihong Zhang, Gregory N. Fuller, Jinsong Liu
Am J Surg Pathol. Author manuscript; available in PMC 2017 Jun 1.
Published in final edited form as: Am J Surg Pathol. 2016 Jun; 40(6): 847–856. doi: 10.1097/PAS.0000000000000635
PMCID:
PMC4864123
AbstractArticlePDF–3.5M
14.
A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population
Moria H Belanger, Lena Dolman, Suzanna L Arcand, Zhen Shen, George Chong, Anne-Marie Mes-Masson, Diane Provencher, Patricia N Tonin
J Ovarian Res. 2015; 8: 1. Published online 2015 Mar 27. doi: 10.1186/s13048-015-0124-8
PMCID:
PMC4376165
AbstractArticlePDF–421K
15.
Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study
Marline G. Harmsen, Marieke Arts-de Jong, Nicoline Hoogerbrugge, Angela H. E. M. Maas, Judith B. Prins, Johan Bulten, Steven Teerenstra, Eddy M. M. Adang, Jurgen M. J. Piek, Helena C van Doorn, Marc van Beurden, Marian J. E. Mourits, Ronald P. Zweemer, Katja N. Gaarenstroom, Brigitte F. M. Slangen, M. Caroline Vos, Luc R. C. W. van Lonkhuijzen, Leon F. A. G. Massuger, Rosella P. M. G. Hermens, Joanne A. de Hullu
BMC Cancer. 2015; 15: 593. Published online 2015 Aug 19. doi: 10.1186/s12885-015-1597-y
PMCID:
PMC4541725
AbstractArticlePDF–1.3M
16.
CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells
X Qiu, C Klausen, J-C Cheng, P C K Leung
Cell Death Dis. 2015 Aug; 6(8): e1864. Published online 2015 Aug 27. doi: 10.1038/cddis.2015.229
PMCID:
PMC4558516
AbstractArticlePDF–1.9M
17.
Morphological and Molecular Characteristics of Mixed Epithelial Ovarian Cancers
Robertson Mackenzie, Aline Talhouk, Sima Eshragh, Sherman Lau, Daphne Cheung, Christine Chow, Nhu Le, Linda S Cook, Nafisa Wilkinson, Jacqueline McDermott, Naveena Singh, Friedrich Kommoss, Jacobus Pfisterer, David G Huntsman, Martin Köbel, Stefan Kommoss, C Blake Gilks, Michael S Anglesio
Am J Surg Pathol. Author manuscript; available in PMC 2016 Nov 1.
Published in final edited form as: Am J Surg Pathol. 2015 Nov; 39(11): 1548–1557. doi: 10.1097/PAS.0000000000000476
PMCID:
PMC4604016
AbstractArticlePDF–1.6M
18.
A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype
Verena Rohnalter, Katrin Roth, Florian Finkernagel, Till Adhikary, Julia Obert, Kristina Dorzweiler, Maike Bensberg, Sabine Müller-Brüsselbach, Rolf Müller
Oncotarget. 2015 Nov 24; 6(37): 40005–40025. Published online 2015 Oct 19. doi: 10.18632/oncotarget.5552
PMCID:
PMC4741876
AbstractArticlePDF–11M
19.
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
Sally M. Hunter, Michael S. Anglesio, Georgina L. Ryland, Raghwa Sharma, Yoke-Eng Chiew, Simone M. Rowley, Maria A. Doyle, Jason Li, C. Blake Gilks, Phillip Moss, Prue E. Allan, Andrew N. Stephens, David G. Huntsman, Anna deFazio, David D. Bowtell, Australian Ovarian Cancer Study Group, Kylie L. Gorringe, Ian G. Campbell
Oncotarget. 2015 Nov 10; 6(35): 37663–37677. Published online 2015 Oct 19. doi: 10.18632/oncotarget.5438
PMCID:
PMC4741956
AbstractArticlePDF–5.3M
20.
Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials
Michael L. Friedlander, Kenneth Russell, Sherri Millis, Zoran Gatalica, Ryan Bender, Andreas Voss
Int J Gynecol Cancer. 2016 May; 26(4): 648–654. Published online 2016 Mar 18. doi: 10.1097/IGC.0000000000000677
PMCID:
PMC4841290
AbstractArticlePDF–1.0M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center